investigation of the possible involvement of ketonic...

7
[CANCER RESEARCH 35, 652@657, March 1975] SUMMARY 5,6-Dihydro-5-oxo-7, 12-dimethylbenz[ajanthracene and 5,6-dihydro-6-oxo-7, I 2-dimethylbenz[a]anthracene are de scribed. These compounds, which are isomeric with 7, 12- dimethylbenz[ajanthracene-5,6-oxide (the K-region epox ide), were inactive in tests for tumor-initiating activity in mouse skin and tumor production in the s.c. tissue of the mouse. INTRODUCTION The carcinogenic response of animals to polycyclic aro matic hydrocarbons may be mediated by the metabolism of these compounds (10), and in recent years considerable attention has been directed towards Boyland's suggestion (3) that K-region epoxides might be the key intermediates in the carcinogenic action of the hydrocarbons. These epoxides are now known to be formed in the microsomal metabolism of hydrocarbons (12, 13, 17, 19, 28), and many of them exhibit high levels of biological activity in tests for malig nant transformation in vitro (14, 16, 20) and in various tests for mutagenic activity (1, 6, 9, 15). However, the K-region epoxides do not exhibit greater carcinogenic potencies than the parent compounds (4, 2 1, 29), and 7-methylbenz[a@an thracene-5,6-oxide does not react with DNA to yield products identical with those formed when the parent hydrocarbon is bound to DNA in cellular systems (2). For these latter reasons we have investigated other derivatives of the polycyclic aromatic hydrocarbons through which their carcinogenic activities might be expressed. The most carcinogenic hydrocarbon metabolites identi fled so far appear to be 3-methylcholanthrene-2-one and 3-methylcholanthrene-l-one (29). Similar ketonic metabo lites were not envisaged for most of the polycyclic hydrocar bon carcinogens because they do not contain the saturated 5-membered ring of cholanthrene. However, recent studies of the mechanismsinvolved in the metabolic hydroxylation of aromatic substrates have shown that the immediate precursors of phenolic metabolites are the keto forms of these phenols which arise as intermediates in the rearrange 1 This work was supported by grants to the Chester Beatty Research Institute and the Paterson Laboratories from the Medical Research Council and the Cancer Research Campaign. Received September 16, 1974; accepted December 6, 1974. ment of an arene oxide (epoxide) to a phenol (7, 18). Since K-region epoxides are known metabolic products for many potent hydrocarbon carcinogens but K-region phenols are not generally found as metabolites of the carcinogenic hydrocarbons(3 1),it is conceivablethat significant amounts of K-region ketones could be formed, and that these putative metabolites could be involved in the carcinogenic action of the polycyclic hydrocarbons. Consistent with the above possibility is the positive correlation between increasing carcinogenic potency and increasing double-bond character at the K-region of polycy clic hydrocarbons (24), together with the expected correla tion between this latter and a decreasing tendency for a K-region ketone to enolize (25). Raha (26, 27) has already indicated that the acid-catalyzed dehydration of cis-4,5- dihydro-4,5-dihydroxybenzo[a]pyrene yields the isomeric K-region ketones in preference to the phenols, although this has not been observed by other workers (5, 30). The present report examines the question of the existence of K-region ketones for carcinogenic and noncarcinogenic hydrocarbons, describes the preparation and characteriza tion of the isomeric K-region ketones derived from the potent carcinogen DM BA,2 and reports results of tests for biological activity of the latter 2 compounds. MATERIALS AND METHODS Chemical Studies3 cis-9, l0-Dihydro-9, lO-dihydroxyphenanthrene, cis-4,5- dihydro-4,5-dihydroxybenzo[a]pyrene and cis-5,6-dihy dro-5,6-dihydroxy-7, 12-dimethylbenz[ajanthracene were prepared by the procedure of Cook and Schoental (5). 9-Phenanthrol was prepared according to the method of Moriconi et al. (22). Isomeric K-Region Ketones of DMBA. cis-5,6-Dihy dro-5,6-dihydroxy-7, 12-dimethylbenz[alanthracene (0.2 g) in glacial acetic acid (50 ml) and water (50 ml) was heated under reflux for 4 hr. After cooling and standing overnight, I The abbreviations used are: DMBA, 7,12-dimethylbenz[ajanthracene; NMR, nuclear magnetic resonance; MEM, Eagle's minimum essential medium. 3 Melting points are corrected and were determined on a microscope hot-stage apparatus. Analyses were by Dr. F. B. Strauss, Microanalytical Laboratories, Oxford, England. 652 CANCER RESEARCH VOL. 35 Investigation of the Possible Involvement of Ketonic Derivatives of Polycyclic Hydrocarbons in Hydrocarbon Carcinogenesis1 Anthony Dipple, Leonard S. Levy, and P. Thomas lype Chester Beatty Research Institute, Institute of Cancer Research, Royal Cancer Hospital, Fulham Road, London, 5W3 6JB [A . D., L. S. L.], and Paterson Laboratories, Christie Hospital and Holt Radium Institute, Manchester M20 9BX, England [P. T. I.] on July 8, 2018. © 1975 American Association for Cancer Research. cancerres.aacrjournals.org Downloaded from

Upload: lamhanh

Post on 13-Jun-2018

215 views

Category:

Documents


0 download

TRANSCRIPT

[CANCER RESEARCH 35, 652@657, March 1975]

SUMMARY

5,6-Dihydro-5-oxo-7, 12-dimethylbenz[ajanthracene and5,6-dihydro-6-oxo-7, I 2-dimethylbenz[a]anthracene are described. These compounds, which are isomeric with 7, 12-dimethylbenz[ajanthracene-5,6-oxide (the K-region epoxide), were inactive in tests for tumor-initiating activity inmouse skin and tumor production in the s.c. tissue of themouse.

INTRODUCTION

The carcinogenic response of animals to polycyclic aromatic hydrocarbons may be mediated by the metabolism ofthese compounds (10), and in recent years considerableattention has been directed towards Boyland's suggestion(3) that K-region epoxides might be the key intermediates inthe carcinogenic action of the hydrocarbons. These epoxidesare now known to be formed in the microsomal metabolismof hydrocarbons (12, 13, 17, 19, 28), and many of themexhibit high levels of biological activity in tests for malignant transformation in vitro (14, 16, 20) and in various testsfor mutagenic activity (1, 6, 9, 15). However, the K-regionepoxides do not exhibit greater carcinogenic potencies thanthe parent compounds (4, 2 1, 29), and 7-methylbenz[a@anthracene-5,6-oxide does not react with DNA to yieldproducts identical with those formed when the parenthydrocarbon is bound to DNA in cellular systems (2). Forthese latter reasons we have investigated other derivatives ofthe polycyclic aromatic hydrocarbons through which theircarcinogenic activities might be expressed.

The most carcinogenic hydrocarbon metabolites identifled so far appear to be 3-methylcholanthrene-2-one and3-methylcholanthrene-l-one (29). Similar ketonic metabolites were not envisaged for most of the polycyclic hydrocarbon carcinogens because they do not contain the saturated5-membered ring of cholanthrene. However, recent studiesof the mechanismsinvolved in the metabolic hydroxylationof aromatic substrates have shown that the immediateprecursors of phenolic metabolites are the keto forms ofthese phenols which arise as intermediates in the rearrange

1 This work was supported by grants to the Chester Beatty Research

Institute and the Paterson Laboratories from the Medical ResearchCouncil and the Cancer Research Campaign.

Received September 16, 1974; accepted December 6, 1974.

ment of an arene oxide (epoxide) to a phenol (7, 18). SinceK-region epoxides are known metabolic products for manypotent hydrocarbon carcinogens but K-region phenols arenot generally found as metabolites of the carcinogenichydrocarbons(31),it is conceivablethat significant amountsof K-region ketones could be formed, and that theseputative metabolites could be involved in the carcinogenicaction of the polycyclic hydrocarbons.

Consistent with the above possibility is the positivecorrelation between increasing carcinogenic potency andincreasing double-bond character at the K-region of polycyclic hydrocarbons (24), together with the expected correlation between this latter and a decreasing tendency for aK-region ketone to enolize (25). Raha (26, 27) has alreadyindicated that the acid-catalyzed dehydration of cis-4,5-dihydro-4,5-dihydroxybenzo[a]pyrene yields the isomericK-region ketones in preference to the phenols, although thishas not been observed by other workers (5, 30).

The present report examines the question of the existenceof K-region ketones for carcinogenic and noncarcinogenichydrocarbons, describes the preparation and characterization of the isomeric K-region ketones derived from thepotent carcinogen DM BA,2 and reports results of tests forbiological activity of the latter 2 compounds.

MATERIALS AND METHODS

Chemical Studies3

cis-9, l0-Dihydro-9, lO-dihydroxyphenanthrene, cis-4,5-dihydro-4,5-dihydroxybenzo[a]pyrene and cis-5,6-dihydro-5,6-dihydroxy-7, 12-dimethylbenz[ajanthracene wereprepared by the procedure of Cook and Schoental (5).9-Phenanthrol was prepared according to the method ofMoriconi et al. (22).

Isomeric K-Region Ketones of DMBA. cis-5,6-Dihydro-5,6-dihydroxy-7, 12-dimethylbenz[alanthracene (0.2 g)in glacial acetic acid (50 ml) and water (50 ml) was heatedunder reflux for 4 hr. After cooling and standing overnight,

I The abbreviations used are: DMBA, 7,12-dimethylbenz[ajanthracene;

NMR, nuclear magnetic resonance; MEM, Eagle's minimum essentialmedium.

3 Melting points are corrected and were determined on a microscope

hot-stage apparatus. Analyses were by Dr. F. B. Strauss, MicroanalyticalLaboratories, Oxford, England.

652 CANCER RESEARCH VOL. 35

Investigation of the Possible Involvement of Ketonic Derivatives ofPolycyclic Hydrocarbons in Hydrocarbon Carcinogenesis1

Anthony Dipple, Leonard S. Levy, and P. Thomas lype

Chester Beatty Research Institute, Institute of Cancer Research, Royal Cancer Hospital, Fulham Road, London, 5W3 6JB [A . D., L. S. L.], andPaterson Laboratories, Christie Hospital and Holt Radium Institute, Manchester M20 9BX, England [P. T. I.]

on July 8, 2018. © 1975 American Association for Cancer Research. cancerres.aacrjournals.org Downloaded from

K-Region Ketones of DMBA

the orange precipitate (0.134 g) was collected and slurriedwith acetone(I ml). The resultant pale-yellow solid (0.074g) was collected, dissolved in benzene, and applied to acolumn of silica gel (40 cm x I sq cm). The column waseluted with benzene containing 1% methanol, which resultedin the elution of an unidentified yellow substance inFractions (10 ml) 4 and 5, followed by the isomeric ketonesin Fractions 8 to 14 and in Fractions 17 to 25. Fractions 8 to14 were pooled and evaporated to dryness, and the residuewas crystallized from benzene yielding 0.019 g of whitecrystals (m.p. 261—262°)which exhibited a maximumabsorption in the UV at 252.5 nm (in 96% ethanol), acarbonyl absorption at I 700 cm@ (in benzene), a peak inthe mass spectrum corresponding to a molecular ion at m/e272, and identical chemical shifts in the NMR spectrum att5, 2.54 ppm for the 2 methyl groups with a signal at ô, 4.23

ppm for the methylene protons (in benzene-d6). On thebasis of the NMR data which were generously providedand interpreted by I. Köhler of the Deutsches Krebsforschungszentrum, Heidelberg, Germany, this isomer wastentatively assigned the 6-oxo structure and identified as5,6-dihydro-6-oxo-7, 12-dimethylbenz[a]anthracene.

C20H@

Calculated: C 88.20, H 5.92Found: C 88.38, H 5.88

Fractions 17 to 25 were pooled and evaporated to dryness,and the residue was crystallized from benzene yielding 0.0 15g of white crystals (m.p. 252.5—254°),which exhibited amaximum absorption in the UV at 251.5 nm (in 96%ethanol), a carbonyl absorption at 1690 cm' (in benzene), apeak in the mass spectrum corresponding to a molecular ionat m/e, 272, and 2 CH3 signals at ô,2.04 ppm (7-CH3) and2.35 ppm (l2-CH3) with a signal at 4.85 ppm assigned to themethylene protons (in benzene-d6). This compound wastherefore assigned the structure 5,6-dihydro-5-oxo-7, 12-dimethylbenz[a]anthracene.

C30H@

Calculated: C 88.20, H 5.92Found: C 88.55,H 5.89

Effect of Acid on Dihydrodiols. These reactions werestudied by spectroscopic and by chromatographic methodsin solutions of glacial acetic acid/water (3/1, v/v) to whichvarious volumes of 32% HCI had been added. For thespectrophotometric studies, the acetic acid solution washeated at 90°,and the reaction was initiated by adding thediol to this solution. Spectra were then recorded at varioustimes. For the chromatographic studies, a more concentrated solution of the diol in acetic acid/water/32% HC1(75/25/0.125 v/v) was heated in an oven at 90°.After timeintervals of 1, 5, and 23 hr, samples were examined bythin-layer chromatography on precoated plastic sheets(Polygram SIL N-HR/UV; Camlab, Cambridge, England)by elution in benzene. All areas of fluorescence or absorption detected in UV were eluted in 96% ethanol, and thespectra of these eluates were examined.

MARCH 1975 653

Biological Studies

Papilloma Induction. The hair was shaved from the backsof male C57BL mice (age 6 to 8 weeks), and 2 days later 0.1zmole of either DMBA (Eastman Kodak Co., Rochester,N. Y.), 5,6-dihydro-5-oxo-7,l2-dimethylbenz[a]anthracene,or 5,6-dihydro-6-oxo-7, 12-dimethylbenz[a]anthracene, eachin benzene (0.05 ml), was applied to the backs of3 groups ofmice. Two other groups of mice received 0.3 @zmoleof either3-methylcholanthrene (Koch-Light, Colnbrook, Buckinghamshire, England) or of 3-methylcholanthrene-l-one (Ii)again in benzene (0.05 ml). After 2 weeks, all mice receivedtwice weekly topical applications of 10 zg of l2-O-tetradecanoyl-phorbol- I 3-acetate (Schuchardt, M unich Germany) in acetone (0.05 ml).

Injections s.c. Groups of female CFLP mice (age 10 to 12weeks) were given a single s.c. injection in the flank of asuspension of the test compound (1 zmole of the DMBAderivatives and 3 zmoles of the 3-methylcholanthrenederivatives) in arachis oil (0.2 ml). The experiment wasterminated after 28 weeks.

Effect of 5,6-Dihydro.-6-oxo.-7,12-dimethylbenz[ajanthracene on Hamster Embryo Cells in Vitro. The method ofDiPaolo et al. (8) was followed, using additional controls.Syrian hamster embryo secondary cells were plated (500cells/60-mm Nunclon dish) either on lethally X-irradiatedrat embryo feeder cells (5000 rads; 5 x l0@cells/dish) or indishes without feeder cells, and maintained in MEM withEarle's salts and supplemented with 10% fetal bovine serum.Dishes were kept at 37°in a humidity cabinet with a gasphase of 5% carbon dioxide in air. A solution of the ketonein acetone was diluted with either MEM or MEM supplemented with 10% fetal bovine serum, so that the finalacetone concentration was 1% and the ketone was present at1 @ig/ml. Cells that had been incubated for 24 hr followinginitial plating were treated with these solutions (2 ml) for 2hr; then all cultures were adjusted to a total volume of 4 mland a serum concentration of 10% and were maintained inthe presence of the ketone for 2, 4, or 6 days, at whichtimes this medium was replaced. The cells were fixed inmethanol and stained with Giemsa on Day 10, and colonieswere examined with a stereomicroscope at x 15.

RESULTS

The only spectral change observed for the acid-catalyzedreaction of 9,10-dihydro-9, lO-dihydroxyphenanthrene was achange in spectrum, with isosbesticpoints at 268 and 288nm, to that exhibited by 9-phenanthrol under these conditions. Similarly, in the chromatographic study, a singleproduct which was inseparable from authentic 9-phenanthrol and which exhibited the same spectral shift in alkali(Table 1) was detected at all time intervals.

The spectral changes associated with the reaction of5,6-dihydro-5,6-dihydroxy-7,12-dimethylbenz[a]anthraceneare illustrated in Chart 1. It can be seen that 2 consecutivereactions occur in this case. The more rapid changes (Chart1A) exhibit an isosbestic point at 274 nm and presumably

on July 8, 2018. © 1975 American Association for Cancer Research. cancerres.aacrjournals.org Downloaded from

RF valuesUV

Ama, (nm) ( x lO@ or@ relative)―Compound BenzeneBenzene/methanol

(9/1)Benzene/methanol

(19/1)cis-9,lO-Dihydro-9,lO-

0.0dihydroxyphenanthrene0.30.2270

(9.8)9-Phenanthrol

0.20.5248.5 (38.6); 252.5i6 (36.2); 276 (10.7): 299 (5.3). Ol-1: 247.5i(23.2); 254 (32.2); 265i (18.3): 273i (14.5): 290i (7.2); 330(6.5)cis-5,6-Dihydro-5,6-dihydroxy-7,

12-di- 0.0methylbenz[a]anthracene0.40.3252i

(2 1); 260 (34); 269 (38.2): 303(7.8)5,6-Dihydro-5-oxo-7,12-dimethylbenz[a)

0.7anthracene0.850.9251.5

(1.0): 295@303i (0.26);366(0.09)5,6-Dihydro-6-oxo-7,

12-dimethylbenz[a] 0. 13anthracene0.850.9252.5

( I .0): 295-303 (0.2);366(0.05)Presumed

mixture of 5-and 6-hydroxy,0.37,l2-dimethylbenz[a]anthracenes241

(0.6); 257 (0.69); 264 (0.74); 298 (1.0): 31 li (0.69): 353 (0.16):374 (0.16). OH-: 264 (1.0): 303 (0.93): 312 (0.90); 326(0.65): 372i(0.20); 388(0.22)cis-4,5-Dihydro-4,5-dihydroxybenzo[a]-

0.0pyrene0.40.25363

(61 ); 272.5 (95); 298 ( I I ); 3 10 ( I I );324(10.5)Presumed

mixture of 4- and 5-hydroxy- 0.2benzo[ajpyrenes266

(1.0); 289 (0.45); 302 (0.47); 380 (0.21); 410 (0.17): OH-: 265i(0.87); 271 (1.0); 308 (0.21): 414(0.06)Second

product (see text) 0.45260i (0.84); 268 ( I .0); 292 (0.52): 304 (0.56); 376 (0.25): 4 11 (0.13).OH: 263i (0.93); 270 (1.0); 304 (0.34): 392 (0.07).

A . Dipple el a!.

Table 1

Chromatographic and spectral properties of hydrocarbon derivatives

a In 96% ethanol. Spectra in alkali were obtained by adding SO@sl N KOH to the ethanolic solution (5 ml).

6 @,point of inflexion.

correspond to the dehydration ofthe diol to a mixture of theisomeric phenols. The slower changes (Chart 1B) exhibitisosbestic points at 262, 317, and 33 1 nm and correspondthen to a tautomerism ofthe phenols to the isomeric ketoneswhich exhibit spectra (Table 1) that are very similar to thefinal spectra obtained in this reaction. The chromatographicstudies were essentially consistent with these observations,since only 3 UV-absorbing products were detected. The 2slowest-moving products had spectra corresponding to thoseof the isomeric ketones and showed no shift in spectrum inalkali (Table I). The faster-moving fluorescent product wasassumed to represent a mixture ofthe isomeric phenols, butit was difficult to obtain reliable spectra since tautomerismto the ketones apparently occurred fairly rapidly either onthe chromatogram itself or during the elution procedure.The spectral data given for the phenols in Table 1 wereobtained by elution of the major product in the acetoneextract of the crude product in the preparative experimentsdescribed in “Materials and Methods.―

The spectral changes associated with the reaction of4,5-dihydro-4,5-dihydroxybenzo[a]pyrene are illustrated inChart 2. Again, 2 consecutive reactions occur, the 1stexhibiting isosbestic points at 259, 279, 309, and 331 nm,and the 2nd exhibiting isobestic points at 309, 347, and 416nm. The 1st series of changes (Chart 2A) are again

a'UC

4

280 XJO\¼veler@th (rai@)

Chart 1. Changes in spectrum with time (mm) for cis-5,6-dihydro-5,6-dihydroxy-7,12-dimethylbenz[a]anthracene in acetic acid/water/32% HC175/25/O.l25v/v)at90°.

654 CANCER RESEARCH VOL. 35

on July 8, 2018. © 1975 American Association for Cancer Research. cancerres.aacrjournals.org Downloaded from

K-regiondihydrodiolofHalf-life

(min) [email protected]@al125M1Phenanthrene2818134DMBA1815124Benzo[a)pyrene2515104

K-Region Ketones of DMBA

reactions, i.e., at 262 or 331 nm in the 1st case and at 347nm in the 2nd. Precise data could not be obtained for thekinetics of the tautomerism of the DMBA phenols, but itwas clear that this reaction was most rapid in the absence ofmineral acid (t½,approximately 1 hr), while at the highestconcentration of HCI used (Chart 1), tautomerism was theslowest (t½,approximately 8 hr). Moreover, at the high HC1concentration, changes in absorption with time were almostlinear rather than logarithmic, suggesting a reaction of zeroorder.

The isomeric K-region ketones of DMBA were preparedand isolated as described under “Materialsand Methods―and experiments were then undertaken to compare thecarcinogenic potencies of these compounds with that ofDMBA itself. At the same time, further comparisons weremade of the relative carcinogenic activities of 3-methylcholanthrene and 3-methylcholanthrene-1-one, since previous studies have compared these compounds only at highdoses where both compounds exhibited high activities (29).

The data obtained from these experiments are summarized in Table 3, where it can be seen that all the ketoderivatives exhibited considerably lower carcinogenic activities than their respective parent hydrocarbons. The K-region ketones of DMBA were inactive under the conditionsof the initiation-promotion experiment and the s.c. injectionexperiment, while a high yield of tumors wasobtained withDMBA in both these experiments. 3-Methylcholanthrene-l-one was inactive in the skin, and although the previouslyreported activity of this compound in the s.c. tissue of themouse (29) was confirmed, it exhibited a lower tumorigenic activity than 3-methylcholanthrene itself in thissystem.

The K-region epoxides of some polycyclic hydrocarbonsexhibit high activities in assays for transformation in vitro(14, 16), despite their rather low carcinogenic activities (4,21, 29). For this reason a preliminary examination of thebiological effects of 5,6-dihydro-6-oxo-7, l2-dimethylbenz[ajanthracene on cells in culture was undertaken. The poorsolubility of this ketone precluded extensive studies but, at 1@g/ml,this compound reducedplating efficiency to 2.2, 2.0,

and 1.4%(control value, 3.1%)for hamster embryo secondary cells exposed for 2, 4, and 6 days, respectively, and to9.8, 9.2, and 9.1% (control value, 10.8%) for the same cellsplated onto a layer of feeder cells. The morphology of allcolonies was examined and no transformed colonies weredetected in any of the dishes with feeder cells where 1302control (acetone only) and 1314 treated colonies were

Table2

Half-life for dehydration ofdihydrodiols in acetic acid/water (3/I)containing the indicated volumes of32% HCI per 100 ml

a'

20

4

Chart 2. Changes in spectrum with time (mm) for cis-4,5-dihydro-4,5-dihydroxybenzo[ajpyrene. Conditions as described in Chart 1.

presumed to correspond to the dehydration ofthe diol to theisomeric phenols, but since the 2nd series of changes resultin an overall loss of UV-absorption and do not yield spectracorresponding to those previously reported by Raha (27) forthe ketones, the nature of this 2nd reaction is not obvious.The chromatographic study showed that after 1 hr allstarting material was gone, and a single fluorescent product(RF, 0.2) which exhibited a spectral shift in alkali, and

therefore, the properties expected of the 4- and 5-benzo[a]-pyrenols (Table 1), was formed. After 5 hr. a 2nd productwhich must have arisen from the phenols and which alsoshowed a spectral shift in alkali (Table 1) was detected atRF, 0.45 while, after 23 hr, no UV-absorbing products weredetected. The K-region ketones described by Raha (27) werenot found, but ifthe fluorescent band (RF, 0.2), presumed tobe the K-region phenols of benzo[a]pyrene, was left on thechromatogram for several days prior to elution in 96%ethanol, it took on a reddish-brown coloration and itsabsorption spectrum then resembled that attributed byRaha (27) to the ketones; i.e., it exhibited a maximumabsorption at 272 nm and no longer exhibited any spectralshift in alkali. This material was not obtained in sufficientquantity for further characterization to be attempted and itremains possible that, while tautomerism to ketones did notoccur under the conditions used in this study, it couldpossibly occur under other conditions.

For the dehydration reactions of all the diols, pseudo1st-order kinetics were followed, and the rates of all thesereactions increased with increasing concentrations of HC1 inthe reaction mixture (Table 2). The kinetics of thesereactions for the DMBA and benzo[a]pyrene derivativeswere examined by measurement of changes in absorption atwavelengths where isosbestic points were found in the 2nd

260 280 300 320 340 360 400Waveier@th (rMO)

655MARCH 1975

on July 8, 2018. © 1975 American Association for Cancer Research. cancerres.aacrjournals.org Downloaded from

No.ofmale C57BL micepapillomas atwithTumor

incidence infemale CFLP miceNo.

ofsurvivorsNo.

ofNo. ofNo. ofwithoutC57BLDoseCFLPmicewith tumorsNo. andtypesCompoundmice(@.amole)I

I wk16 wk 19 wk23 wkmiceDoses.c. tumors at 28 wkoftumorsDMBA270.16(1.5)21

(2.5) 27(3.1)18I @mole13(16)― 44squamous carcinomas

8 sarcomasIcarcinosarcoma―5,6-Dihydro-5-oxo

260. 100 0201 @imole020DMBA5,6-Dihydro-6-oxo

270. I00 0201 @amole020DMBA3-Methylcholanthrene260.303(1.0)

8(1.1)14(1.4)[email protected](15) 43

squamous carcinomas8sarcomas3 carcinosarcomaI adenocarcinomaI squamouscarcinoma3-Methylcholanthrene

270.300 00203 MmolesI 1 (20) 88sarcomasI-one2adenocarcinomasArachisoil(control)200.2ml0

17

A. Dipple et a!.

Table 3

Carcinogenicity tests of hydrocarbon derivatives

a Mean latent period in weeks (mean latent period is taken as the time period from injection to the 1st palpable evidence of lesion presence).

b “Carcinosarcoma― describes the histological appearance of the malignant lesion, but it is not clear whether these tumors are of mesenchymal or

epithelial origin.C Papillomas per tumor-bearing mouse.

examined. In the dishes without feeder cells, only I transformed colony was detected in a dish treated with ketone for4 days, among a total of 27 1 colonies examined, and notransformed colonies were detected in the 306 coloniesexamined in the control.

DISCUSSION

The chemical studies show that the primary products ofthe acid-catalyzed dehydration of the 3 hydrocarbon K-region cis-dihydrodiols are, in each case, the K-regionphenols. In agreement with the previous studies of Moriconiet a!. (22), the K-region phenol from the noncarcinogenphenanthrene showed no tendency to tautomerize to aketo form. The phenolic products obtained from the benzo[ajpyrene derivative were not particularly stable and, underthe conditions used, gave rise to other products which werenot ketones. However, compounds with properties consistent with those expected for K-region ketones have beendescribed previously (27).

The studies of the dihydrodiol from the potent carcinogenDMBA were more conclusive. It was found that the phenolsrearranged into their keto forms and that these latterproducts, unlike the phenols themselves, could be isolated asstable crystalline solids. Since both isomeric ketones wereobtained, it follows that both the 5- and 6-hydroxy derivatives must result from the initial dehydration reaction,although it has previously been thought that the 5-hydroxyderivative is obtained exclusively (23). It appears from thesestudies that the keto forms of the K-region phenols ofDMBA are much more stable than the enol forms. Although fairly vigorous chemical conditions were used to

establish this point, the mechanistic studies of the metabolism of model aromatic substrates (7, 18) suggest that anarene oxide rearranges initially to a ketone, and that aphenol is produced by a subsequent enolization step.

In the case of DMBA, it is clear that if a similarmechanism were involved, enolization would not occur andK-region phenols would not be produced. In fact, K-regionphenols are not found as metabolites of DMBA (31), so it isconceivable that K-region ketones may accumulate in thiscase, although their presence has not been reported. However, small amounts of K-region phenol are detected when7, 12-dimethylbenz[a]anthracene-5,6-oxide is subjected tometabolism in rat liver homogenates (32). This phenol mustpresumably arise, therefore, via a direct rearrangement ofthe epoxide to the phenol in which no NIH shift should beinvolved.

In the biological studies with the K-region ketones ofDMBA, a marked absence of carcinogenic activity wasnoted. 3-Methylcholanthrene-l-one was also inactive intests for papilloma initiation activity, but it did producetumors after s.c. injection in mice, although it was clearlyless active than the parent compound.

Preliminary studies of the ability of 5,6-dihydro-6-oxo-7, 12-dimethylbenz[a]anthracene to elicit transformation of hamster embryo cells in vitro did not reveal anysignificant transforming activity, but some toxicity wasapparent. In parallel experiments using DMBA and feedercells, the parent compound did cause significant transformation at doses that resulted in cytotoxic effects similar tothose observed in the present study (33). However, sinceDMBA was not reexamined concurrently with the ketone,firm conclusions regarding the relative activities of these

656 CANCER RESEARCH VOL. 35

on July 8, 2018. © 1975 American Association for Cancer Research. cancerres.aacrjournals.org Downloaded from

K-Region Ketones of DMBA

compounds in the in vitro system cannot be reached.Nevertheless, the data presented herein suggest that thisketone does not exhibit the properties attributed to theK-region epoxides of some hydrocarbons, i.e., a low carcinogenic activity in animal studies (4, 21, 29) but a notablyhigh activity in assays for in vitro transformation (14, 16).

Whereas it is difficult to prove conclusively that aparticular hydrocarbon derivative is not involved in thecarcinogenic action of the parent polycyclic hydrocarbon,the absence of any significant carcinogenic or transformingactivity for the K-region ketones of DMBA stronglysuggests that these compounds do not mediate in thecarcinogenic action of DM BA.

ACKNOWLEDGMENTSWe are grateful to our colleague, Dr. M. Jarman, for mass spectral

studies; to I. Köhler of the Institut fürBiochemie (Director, Dr. E. H.Hecker), Deutsches Krebsforschungszentrum, Heidelberg, Germany, forthe NMR studies: to T. A. Slade and S. Gamble for assistance with theanimal studies; and to Dr. R. L. Carter for advice on the histopathology.

REFERENCES1. Ames, B. N., Sims, P., and Grover, P. L. Epoxides of Carcinogenic

Polycyclic Hydrocarbons are Frameshift Mutagens. Science, 176:47—49.1972.

2. Baird, W. M., Dipple, A., Grover, P. L., Sims, P., and Brookes, P.

Studies on the Formation of Hydrocarbon-Deoxyribonucleoside Products by the Binding of Derivatives of 7-Methylbenz[a]anthracene toDNA in Aqueous Solution and in Mouse Embryo Cells in Culture.Cancer Res., 33 2386—2392, 1973.

3. Boyland, E. The Biological Significance of Metabolism of Polycyclic

Compounds. Biochem. Soc. Symp., 5: 40—54,1950.

4. Boyland, E., and Sims, P. Carcinogenic Activities in Mice ofCompounds Related to Benz[a]anthracene. Intern. J. Cancer, 2:500—504,1967.

5. Cook, J. W., and Schoental, R. Oxidation ofCarcinogenic Hydrocarbons by Osmium Tetroxide. J. Chem. Soc., 170—173,1948.

6. Cookson, M. J., Sims, P., and Grover, P. L. Mutagenicity of Epoxidesof Polycyclic Hydrocarbons Correlates with Carcinogenicity of ParentHydrocarbon. Nature New Biol., 234: 186—187,1971.

7. Daly, J. W., Jerina, D. M., and Witkop, B. Arene Oxides and the NIH

Shift: The Metabolism, Toxicity and Carcinogenicity of AromaticCompounds. Experientia, 28: 1129-1264, 1972.

8. DiPaolo, J. A., Donovan, P. J., and Nelson, R. L. Quantitative Studiesof in vitro Transformation by Chemical Carcinogens. J. NatI. CancerInst.,42:867—874,1969.

9. Fahmy, 0. G., and Fahmy, M. J. Oxidative Activation of Benz[a]anthracene and Methylated Derivatives in Mutagenesis and Carcinogenesis. Cancer Res., 33: 2354—2361, 1973.

10. Fieser, L. F. Carcinogenic Activity, Structure and Chemical Reactivityof Polycyclic Aromatic Hydrocarbons. Am. J. Cancer, 34: 37—124,1938.

I I . Fieser, L. F., and Hershberg, E. B. The Oxidation of Methylcholanthrene and 3,4-Benzpyrene with Lead Tetraacetate; Further Derivatives of 3,4-Benzpyrene. J. Am. Chem. Soc., 60: 2542—2548, 1938.

12. Grover, P. L., Hewer, A., and Sims, P. Epoxides as MicrosomalMetabolities of Polycyclic Hydrocarbons. Federation European Biochem. Soc. Letters, 18: 76—79,1971.

13. Grover. P. L., Hewer, A.. and Sims, P. Formation of K-regionEpoxides as Microsomal Metabolites of Pyrene and Benzo[a]pyrene.Biochem. Pharmacol., 21: 2713—2726, 1972.

14. Grover, P. L., Sims, P., Huberman, E., Marquardt, H., Kuroki, T.,

and Heidelberger, C. In Vitro Transformation of Rodent Cells by

K-region Derivatives of Polycyclic Hydrocarbons. Proc. Natl. Acad.Sci.U. S.,68: 1098—1101,1971.

15. Huberman, E., Aspiras, L., Heidelberger, C., Grover, P. L., and Sims,P. Mutagenicity to Mammalian Cells of Epoxides and Other Derivatives of Polycyclic Hydrocarbons. Proc. Natl. Acad. Sci. U. S., 68:

3195—3199,1971.

16. Huberman, E., Kuroki, T., Marquardt, H., Selkirk, J. K., Heidelberger, C., Grover, P. L., and Sims, P. Transformation of HamsterEmbryo Cells by Epoxides and Other Derivatives of PolycyclicHydrocarbons. Cancer Res., 32: 1391—1396, 1972.

17. Jerina, D. M., Daly, J. W., Witkop, B., Zaltzman-Nirenberg, P., andUdenfriend, S. The Role of Arene Oxide-Oxepin Systems in theMetabolism of Aromatic Substrates. III. Formation of 1,2-Naphthalene Oxide from Naphthalene by Liver Microsomes. J. Am. Chem.

Soc.,90:6525—6527,1968.

18. Kasperek, G. J., Bruice, T. C., Yagi, H., and Jerina, D. M.Differentiation between the Concerted and Stepwise Mechanisms forAromatization (NIH-Shift) of Arene Epoxides. J. Chem. Soc. Sec. DChem. Commun., 784—785, 1972.

19. Keysell, G. R., Booth, J., Sims, P., Grover, P. L., and Hewer, A. TheFormation of an Epoxide in the Microsomal Metabolism of 7,12-Dimethylbenz[a]anthracene. Biochem. J., 129: 4l—42p.1972.

20. Marquardt, H., Kuroki, T., Huberman, E., Selkirk, J. K., Heidelberger, C., Grover, P. L., and Sims, P. Malignant Transformation of CellsDerived from Mouse Prostate by Epoxides and Other Derivatives ofPolycyclic Hydrocarbons. Cancer Res., 32: 716—720, 1972.

21. Miller, E. C., and Miller, J. A. Low Carcinogenicity of the K-regionEpoxides of 7-Methylbenz[a]anthracene and Benz[a]anthracene in theMouse and Rat. Proc. Soc. Exptl. Biol. Med., 124: 915—919, 1967.

22. Moriconi, E. J., Wallenberger, F. T., and O'Connor, W. F. A NewSynthesis of 9-Phenanthrol: Absorption Spectra of the Quinhydrone-Iype Molecular Compound between 9-Phenanthrol and Phenanthraquinone. J. Org. Chem., 24: 86—90,1959.

23. Newman, M. S., and Davis, C. C. The Syntheses of 3,4-Dimethoxy-9,l0-dimethyl-I,2-benzanthracene and 9,10-Dimethyl-l,2-ben

zanthra-3,4-quinone. J. Org. Chem., 32: 66—68,1967.24. Pullman, A., and Pullman, B. Electronic Structure and Carcinogenic

Activity of Aromatic Molecules. New Developments. Advan. CancerRes.,3: 117—169,1955.

25. Pullman, A., and Pullman, B. A Quantum Chemist's Approach to theMechanism of Chemical Carcinogenesis. In: E. D. Bergmann and B.Pullman (eds.), Jerusalem Symposia on Quantum Chemistry andBiochemistry. Physicochemical Mechanisms of Carcinogenesis, Vol.1, pp. 9—24.Jerusalem: Israel Academy of Sciences and Humanities,1969.

26. Raha, C. R. Métabolites Comportant la Region-K. Bull. Soc. Chim.Biol., 52: 105—107,1970.

27. Raha, C. R. Metabolism of Benzo[ajpyrene at the 4,5-Position. IndianJ.Biochem.,9:105—110,1972.

28. Selkirk, J. K., Huberman, E., and Heidelberger, C. An Epoxide is anIntermediate in the Microsomal Metabolism ofthe Chemical Carcinogen, Dibenz[a,h]anthracene. Biochem. Biophys. Res. Commun., 43:1010—1016,1971.

29. Sims, P. The Carcinogenic Activities in Mice of Compounds Relatedto 3-Methylcholanthrene. Intern. J. Cancer, 2: 505—508, 1967.

30. Sims, P. The Metabolism of Benzo[a]pyrene by Rat-Liver Homoge

nates. Biochem. Pharmacol., 16: 613—618, 1967.3 1. Sims, P. Qualitative and Quantitative Studies on the Metabolism of a

Series of Aromatic Hydrocarbons by Rat-Liver Preparations. Biochem. Pharmacol., 19: 795—818, 1970.

32. Sims, P. The Preparation and Metabolism of Epoxides Related to7,12-Dimethylbenz[a]anthracene. Biochem. J., 131: 405—413,1973.

33. Umeda, M., and lype, P. T. An Improved Expression of in vitroTransformation Rate Based on Cytotoxicity Produced by ChemicalCarcinogens. Brit. J. Cancer, 28: 71—74,1973.

MARCH 1975 657

on July 8, 2018. © 1975 American Association for Cancer Research. cancerres.aacrjournals.org Downloaded from

1975;35:652-657. Cancer Res   Anthony Dipple, Leonard S. Levy and P. Thomas Iype  of Polycyclic Hydrocarbons in Hydrocarbon CarcinogenesisInvestigation of the Possible Involvement of Ketonic Derivatives

  Updated version

  http://cancerres.aacrjournals.org/content/35/3/652

Access the most recent version of this article at:

   

   

   

  E-mail alerts related to this article or journal.Sign up to receive free email-alerts

  Subscriptions

Reprints and

  [email protected] at

To order reprints of this article or to subscribe to the journal, contact the AACR Publications

  Permissions

  Rightslink site. Click on "Request Permissions" which will take you to the Copyright Clearance Center's (CCC)

.http://cancerres.aacrjournals.org/content/35/3/652To request permission to re-use all or part of this article, use this link

on July 8, 2018. © 1975 American Association for Cancer Research. cancerres.aacrjournals.org Downloaded from